Öppen, transparent och målrettet informasjonspolicy
Implenia har en öppen, transparent och målinriktad informationspolicy som skyddar aktieägarnas, investerarnas och allmänhetens intressen. I vår periodiska och pågående rapportering är Implenia - som ett börsnoterat företag - engagerat i lika behandling av alla intressenter när det gäller tidpunkt och innehåll. Under länken "Nyhetstjänst" kan du registrera dig för våra pressmeddelanden och beställa tryckta kopior av vår årsredovisning och halvårsrapport.
Implenia sells its ferry dock maintenance and rock support business in Norway
A subsidiary of Presis Infra AS is acquiring Implenia’s ferry dock maintenance and rock support business in the north of Norway.
Implenia upgrades St. Gallen city expressway as part of joint venture
Switzerland’s Federal Roads Office (FEDRO) has awarded a contract for construction work on the St. Gallen city expressway, worth CHF 165.1 million, to the “Stadtautobahn” joint venture, in which Implenia has a 30% share.
2021 Annual General Meeting of Shareholders: Shareholders approve all proposals
2020 financial statements approved | All existing members of the Board of Directors confirmed for another term | No distribution of a dividend
Implenia to acquire BAM Swiss AG to strengthen its healthcare buildings construction presence in Switzerland
With the agreed acquisition of BAM Swiss AG, Implenia becomes a leading construction services provider in the healthcare sector, strengthening market presence in Switzerland | Division Buildings expands capabili¬ties for complex large-scale projects | Employees of BAM Swiss AG planned to join Implenia | Implenia will ensure planning and realisation of Aarau Cantonal Hospital from a single source
Implenia-led joint venture wins contract to build northern access shaft on the Gotthard
The Swiss Federal Roads Office (FEDRO) has awarded the CHF 86.6 million contract to build a 4 km access shaft for the second Gotthard tube (Lot 243) to the 'secondo tubo' joint venture between Implenia, Webuild Group / csc and Frutiger.